The official Team Kentucky source for information concerning COVID-19

Team Kentucky - Kentucky Cabinet for Health and Family Services - Department for Public Health

Regional COVID-19 Monoclonal Antibody Administration Centers


OMICRON VARIANT UPDATE:

Two of the three monoclonal antibodies FDA-authorized for COVID-19 in the United States, REGEN-COV and bam/ete, are ineffective against the Omicron variant. As such, new shipments of REGEN-COV and bam/ete to Kentucky have ended as of January 3, 2022. The third FDA-authorized monoclonal antibody, sotrovimab, is available nationwide in only very limited quantities. Unless sotrovimab supplies increase and/or new monoclonal antibodies effective against the Omicron variant are released, supplies in Kentucky will be extremely limited and many treatment locations will not have monoclonal antibodies to offer at their sites. We urge all eligible persons 5 and older to get vaccinated and/or boosted with a Moderna or Pfizer mRNA COVID-19 vaccine to prevent serious and/or life-threatening COVID-19 disease.

Evusheld Fact Sheet

Centers for Disease Control and Prevention

Visit CDC.gov